Logo image of EXO.AS

EXOR NV (EXO.AS) Stock Fundamental Analysis

AMS:EXO - Euronext Amsterdam - NL0012059018 - Common Stock - Currency: EUR

83.9  -0.1 (-0.12%)

Fundamental Rating

3

Taking everything into account, EXO scores 3 out of 10 in our fundamental rating. EXO was compared to 47 industry peers in the Financial Services industry. The financial health of EXO is average, but there are quite some concerns on its profitability. EXO has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

EXO had positive earnings in the past year.
In the past year EXO had a positive cash flow from operations.
Of the past 5 years EXO 4 years were profitable.
In the past 5 years EXO always reported a positive cash flow from operatings.
EXO.AS Yearly Net Income VS EBIT VS OCF VS FCFEXO.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B

1.2 Ratios

The Return On Assets of EXO (34.55%) is better than 100.00% of its industry peers.
EXO has a better Return On Equity (38.39%) than 87.23% of its industry peers.
Industry RankSector Rank
ROA 34.55%
ROE 38.39%
ROIC N/A
ROA(3y)14.68%
ROA(5y)9.18%
ROE(3y)25.64%
ROE(5y)17.39%
ROIC(3y)N/A
ROIC(5y)N/A
EXO.AS Yearly ROA, ROE, ROICEXO.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for EXO so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
EXO.AS Yearly Profit, Operating, Gross MarginsEXO.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15 20 25

More info and screens

4

2. Health

2.1 Basic Checks

EXO does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, EXO has less shares outstanding
Compared to 5 years ago, EXO has less shares outstanding
The debt/assets ratio for EXO has been reduced compared to a year ago.
EXO.AS Yearly Shares OutstandingEXO.AS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
EXO.AS Yearly Total Debt VS Total AssetsEXO.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50B 100B 150B

2.2 Solvency

An Altman-Z score of 3.82 indicates that EXO is not in any danger for bankruptcy at the moment.
EXO has a better Altman-Z score (3.82) than 74.47% of its industry peers.
The Debt to FCF ratio of EXO is 87.02, which is on the high side as it means it would take EXO, 87.02 years of fcf income to pay off all of its debts.
EXO has a Debt to FCF ratio of 87.02. This is in the lower half of the industry: EXO underperforms 72.34% of its industry peers.
EXO has a Debt/Equity ratio of 0.08. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of EXO (0.08) is better than 78.72% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF 87.02
Altman-Z 3.82
ROIC/WACCN/A
WACC7.07%
EXO.AS Yearly LT Debt VS Equity VS FCFEXO.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B 50B

2.3 Liquidity

A Current Ratio of 0.19 indicates that EXO may have some problems paying its short term obligations.
EXO's Current ratio of 0.19 is on the low side compared to the rest of the industry. EXO is outperformed by 74.47% of its industry peers.
A Quick Ratio of 0.19 indicates that EXO may have some problems paying its short term obligations.
The Quick ratio of EXO (0.19) is worse than 74.47% of its industry peers.
Industry RankSector Rank
Current Ratio 0.19
Quick Ratio 0.19
EXO.AS Yearly Current Assets VS Current LiabilitesEXO.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B

More info and screens

2

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 262.89% over the past year.
Measured over the past years, EXO shows a very strong growth in Earnings Per Share. The EPS has been growing by 38.47% on average per year.
EXO shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -100.00%.
EPS 1Y (TTM)262.89%
EPS 3Y104.89%
EPS 5Y38.47%
EPS Q2Q%-101.27%
Revenue 1Y (TTM)-100%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-100%

3.2 Future

EXO is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -49.89% yearly.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-77.23%
EPS Next 2Y-52.5%
EPS Next 3Y-49.89%
EPS Next 5YN/A
Revenue Next Year6.69%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EXO.AS Yearly Revenue VS EstimatesEXO.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50B 100B 150B
EXO.AS Yearly EPS VS EstimatesEXO.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 10 20 30

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 1.25, the valuation of EXO can be described as very cheap.
Based on the Price/Earnings ratio, EXO is valued cheaper than 95.74% of the companies in the same industry.
When comparing the Price/Earnings ratio of EXO to the average of the S&P500 Index (28.10), we can say EXO is valued rather cheaply.
The Price/Forward Earnings ratio is 10.77, which indicates a very decent valuation of EXO.
Based on the Price/Forward Earnings ratio, EXO is valued a bit cheaper than 68.09% of the companies in the same industry.
EXO's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 20.74.
Industry RankSector Rank
PE 1.25
Fwd PE 10.77
EXO.AS Price Earnings VS Forward Price EarningsEXO.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

72.34% of the companies in the same industry are cheaper than EXO, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 394.47
EV/EBITDA N/A
EXO.AS Per share dataEXO.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 50 100 150

4.3 Compensation for Growth

EXO's earnings are expected to decrease with -49.89% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)0.03
EPS Next 2Y-52.5%
EPS Next 3Y-49.89%

More info and screens

2

5. Dividend

5.1 Amount

With a yearly dividend of 0.55%, EXO is not a good candidate for dividend investing.
EXO's Dividend Yield is comparable with the industry average which is at 4.05.
Compared to an average S&P500 Dividend Yield of 2.43, EXO's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.55%

5.2 History

The dividend of EXO decreases each year by -47.20%.
Dividend Growth(5Y)-47.2%
Div Incr Years1
Div Non Decr Years1
EXO.AS Yearly Dividends per shareEXO.AS Yearly Dividends per shareYearly Dividends per share 2023 2024 2025 0.1 0.2 0.3 0.4

5.3 Sustainability

0.67% of the earnings are spent on dividend by EXO. This is a low number and sustainable payout ratio.
The Dividend Rate of EXO has been decling, while earnings will also be declining. This means the current dividend is most likely not sustainable.
DP0.67%
EPS Next 2Y-52.5%
EPS Next 3Y-49.89%
EXO.AS Yearly Income VS Free CF VS DividendEXO.AS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B
EXO.AS Dividend Payout.EXO.AS Dividend Payout, showing the Payout Ratio.EXO.AS Dividend Payout.PayoutRetained Earnings

More info and screens

EXOR NV

AMS:EXO (5/5/2025, 7:00:00 PM)

83.9

-0.1 (-0.12%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryFinancial Services
Earnings (Last)03-26 2025-03-26/amc
Earnings (Next)09-17 2025-09-17
Inst Owners27.54%
Inst Owner ChangeN/A
Ins Owners0%
Ins Owner ChangeN/A
Market Cap18.54B
Analysts85
Price Target120.36 (43.46%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.55%
Yearly Dividend0.46
Dividend Growth(5Y)-47.2%
DP0.67%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-4.16%
PT rev (3m)-3.38%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)2.39%
EPS NY rev (3m)-13.37%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 1.25
Fwd PE 10.77
P/S N/A
P/FCF 394.47
P/OCF 394.47
P/B 0.49
P/tB 0.49
EV/EBITDA N/A
EPS(TTM)66.88
EY79.71%
EPS(NY)7.79
Fwd EY9.28%
FCF(TTM)0.21
FCFY0.25%
OCF(TTM)0.21
OCFY0.25%
SpS0
BVpS172.92
TBVpS172.92
PEG (NY)N/A
PEG (5Y)0.03
Profitability
Industry RankSector Rank
ROA 34.55%
ROE 38.39%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)14.68%
ROA(5y)9.18%
ROE(3y)25.64%
ROE(5y)17.39%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF 87.02
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 0.32%
Current Ratio 0.19
Quick Ratio 0.19
Altman-Z 3.82
F-Score5
WACC7.07%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)46.89%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)262.89%
EPS 3Y104.89%
EPS 5Y38.47%
EPS Q2Q%-101.27%
EPS Next Y-77.23%
EPS Next 2Y-52.5%
EPS Next 3Y-49.89%
EPS Next 5YN/A
Revenue 1Y (TTM)-100%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-100%
Revenue Next Year6.69%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-108.87%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-98.63%
FCF growth 3Y-69.35%
FCF growth 5Y-53.45%
OCF growth 1Y-99.25%
OCF growth 3Y-76.44%
OCF growth 5Y-67.23%